Bone metabolism in advanced cholestatic liver disease: Analysis by bone histomorphometry

被引:70
|
作者
Guichelaar, MMJ
Malinchoc, M
Sibonga, J
Clarke, BL
Hay, JE
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biostat, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Orthoped, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Endocrinol, Rochester, MN 55905 USA
[5] Univ Groningen Hosp, Div Liver Transplantat, Groningen, Netherlands
关键词
D O I
10.1053/jhep.2002.36357
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Despite the clinical importance of cholestatic osteopenia, little is known about its pathophysiologic mechanism. By tetracycline-labeled histomorphometric analysis of bone biopsies taken at the time of liver transplantation, we prospectively evaluated bone resorption and formation in 50 consecutive patients with advanced primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). Histomorphometric analysis confirmed low bone volume parameters, consistent with the mean T-score of the lumbar spine of -1.9 by dual energy x-ray absorptiometry. Dynamic (bone formation rates, adjusted apposition rates) and static (osteoid markers, osteoblast number) parameters of bone formation were decreased in cholestatic patients with no abnormalities in mineralization. Increased osteoclast numbers and increased eroded surface areas suggested increased bone resorption, and this was supported in female patients by increased trabecular separation and decreased trabecular number. Male cholestatic patients, however, did not have significant increases in resorption parameters, although they were as osteopenic as female patients and had low bone formation markers. Bone histomorphometric changes were similar in PBC and PSC, suggesting an etiologic effect of chronic cholestasis rather than the individual diseases. Cancellous bone volume and osteoid markers correlated with bone mineral density measurements but no correlations were found between histomorphometric parameters and biochemical markers of bone metabolism. In conclusion, cholestatic osteopenia appears to result from a combination of decreased bone formation and increased resorption, especially in female patients, but the relative importance of these two abnormalities and their actual etiology remain to be elucidated.
引用
收藏
页码:895 / 903
页数:9
相关论文
共 50 条
  • [21] Impairment of bone mass development in children with chronic cholestatic liver disease
    Albuquerque Taveira, Adriana Tavora de
    Machado Fernandes, Maria Inez
    Galvao, Livia Carvalho
    Sawamura, Regina
    Vieira, Enaldo de Mello
    Albuquerque de Paula, Francisco Jose
    CLINICAL ENDOCRINOLOGY, 2007, 66 (04) : 518 - 523
  • [22] Immunotactoid glomerulopathy with extrarenal deposits in the bone, and chronic cholestatic liver disease
    Wallner, M
    Prischl, FC
    Hobling, W
    Haidenthaler, A
    Regele, H
    Ulrich, W
    Kramar, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (08) : 1619 - 1624
  • [23] Bone metabolism in non cholestatic chronic hepatopathy
    Sanz-Agero, PG
    Nunez, FM
    Sosa, JCE
    Cantarero, GG
    Vina, JC
    Cabezudo, MJS
    Gomez, MEM
    MEDICINA CLINICA, 1998, 111 (12): : 446 - 450
  • [25] BONE HISTOMORPHOMETRY AND BIOCHEMICAL PARAMETERS IN POSTBILIOPANCREATIC BYPASS BONE-DISEASE
    COMPSTON, JE
    VEDI, S
    PITTON, L
    WATSON, GJ
    WOODHEAD, JS
    SCOPINARO, N
    BONE, 1985, 6 (05) : 410 - 411
  • [26] Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry
    Parfitt, AM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (04): : 387 - 403
  • [27] Oncofetal fibronectin decreases bone formation and mediates bone loss in patients with chronic cholestatic liver disease
    Kawelke, N.
    Bentmann, A.
    Kasperk, C.
    Felsenberg, D.
    Berger, I
    Singer, M.
    Faessler, R.
    Nakchbandi, I
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 : S88 - S88
  • [28] Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease.
    Hay, JE
    Guichelaar, MM
    Clarke, BL
    Malinchoc, M
    HEPATOLOGY, 2001, 34 (04) : 199A - 199A
  • [29] Bone histomorphometry in patients with inflammatory bowel disease
    Lehmann, G
    Eidner, T
    Stein, G
    Hein, G
    BONE, 2001, 28 (05) : S118 - S118
  • [30] Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients
    Keronen, Satu
    Martola, Leena
    Finne, Patrik
    Burton, Inari S.
    Kauppila, Leena
    Kroger, Heikki
    Larsson, Tobias E.
    Honkanen, Eero
    CLINICAL NEPHROLOGY, 2016, 85 (03) : 127 - 134